Short-Term Pregnancy Outcomes Following Monoclonal Antibody Treatment for COVID-19 Infection during the Omicron Surge

Journal Title: Women's Health Science Journal - Year 2022, Vol 6, Issue 2

Abstract

Background: Monoclonal antibody (mAb) therapy has been recommended in non-hospitalized COVID-19 positive pregnant individuals with mild to moderate symptoms despite data on safety and efficacy. Objective: To assess short-term outcomes of mAb treatment in COVID-19 positive pregnant patients during the Omicron surge. Methods: This is a descriptive study of pregnant patients receiving mAb therapy from December 1, 2021, and March 18, 2022 during the Omicron surge. Patients received either (1) sotrovimab, or (2) bamlanivimab/etesivimab, or (3) casirivimab / imdevimab. We reviewed the medical records of pregnant patients who received mAb, gathering baseline demographics and assessing adverse events from mAb infusion. Results: Twenty-one pregnant patients received mAbs during the Omicron surge. The short-term maternal outcomes for most of our cohort were favorable. One patient developed an anaphylactic reaction following infusion of bamlanivimab/etesevimab. One patient required admission to the intermediate care unit for severe COVID-19 fifteen days following infusion, and a second patient developed cardiorespiratory symptoms concerning for post-acute sequelae SARS-CoV-2 infection. Adverse pregnancy outcomes were present in 43.7% of our delivered cohort (n=16). Conclusion: Short-term outcomes in pregnant patients who received monoclonal antibodies for COVID-19 during the Omicron surge are mostly favorable, with symptom resolution and rare adverse events.

Authors and Affiliations

Loza AJ*, Farias RD, Gavin NR, Wagner RK and Shields AD

Keywords

Related Articles

“Oral Menopause” - Do you know this Phenomenon?

Patients as well as therapists, even dental professionals, are not fully aware of the fact that menopausal oral problems can seriously impair quality of life. However, hormone receptors in the oral mucosa may cause dry m...

Profile and Prognosis of Retro Placental Hematoma Victims at the Regional University Associated Hospital of Borgou (CUAB) in Republic of Benin

Objectives: Describe the prognosis and profile of the retro placental hematoma(RPH) at CUAB for a better organization of care. Methods: This is a descriptive retrospective study, carried out in the obstetric gynecology s...

Adhesiolysis in Women with Chronic Pelvic Pain and a Temporal Resolution of Pain

Study Objectives: To evaluate the duration of pain improvement after laparoscopic and/or robotic assisted adhesiolysis in women with prior abdominal or pelvic surgeries that have been diagnosed with chronic pelvic pain w...

Physical and Psychological Abuse among Women with Disabilities since COVID-19

During the period since coronavirus disease-19 (COVID-19) emerged, women with disabilities might be less likely to receive necessary services in the community because they have been interrupted due to the risk of spread...

Perforating Folliculitis in Pregnancy: A Case Report

Perforating Folliculitis (PF) classified amongst Acquired Perforating Dermatoses can lead to preterm delivery especially in presence of secondary infection. This entity should be kept in mind as a potential cause of pret...

Download PDF file
  • EP ID EP746538
  • DOI 10.23880/whsj-16000167
  • Views 18
  • Downloads 0

How To Cite

Loza AJ*, Farias RD, Gavin NR, Wagner RK and Shields AD (2022). Short-Term Pregnancy Outcomes Following Monoclonal Antibody Treatment for COVID-19 Infection during the Omicron Surge. Women's Health Science Journal, 6(2), -. https://europub.co.uk/articles/-A-746538